Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
Chapter 2. Executive Summary
2.1. Global SKT Market Portraiture
2.2. Global SKT Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global SKT Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Seborrheic Keratosis Treatment (SKT) Market: Market Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Prevalence of Seborrheic Keratosis
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Seborrheic Keratosis TreatmentProposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Seborrheic Keratosis Treatment (SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Surgical Treatment
4.2.1. Cryosurgery
4.2.2. Electrocautery
4.2.3. Curettage
4.2.4. Laser Ablation
4.3. Topical Solution Treatment
4.3.1. Hydrogen Peroxide 40% Solution (Eskata)
4.4. Pipeline Drugs (Qualitative Information)
4.4.1. EPI SK14 (EpiPharm AG)
Chapter 5. Global Seborrheic Keratosis Treatment (SKT) Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America SKT Market, 2016 – 2026 (US$ Mn)
5.2.1. North America SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.2.2. North America SKT Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe SKT Market, 2016 – 2026 (US$ Mn)
5.3.1. Europe SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe SKT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific SKT Market, 2016 – 2026 (US$ Mn)
5.4.1. Asia Pacific SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific SKT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America SKT Market, 2016 – 2026 (US$ Mn)
5.5.1. Latin America SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America SKT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa SKT Market, 2016 – 2026 (US$ Mn)
5.6.1. Middle East & Africa SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.6.2. Middle East & Africa SKT Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Aclaris Therapeutics, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Cortex Technology ApS
6.3. CryoConcepts LP
6.4. Cryoswiss GmbH
6.5. DRE Medical, Inc.
6.6. EpiPharm AG
6.7. H&O Equipments SA
6.8. Orasure Technologies, Inc.
6.9. Special Medical Technology Co., Ltd.
6.10. Wallach Surgical Devices, Inc.
List Of Figures
FIG. 1 Market Segmentation: Global Seborrheic Keratosis Treatment (SKT) Market
FIG. 2 Research Methodology: Global SKT Market
FIG. 3 Global SKT Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global SKT Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: Global SKT Market, by Geography, 2017
FIG. 6 Competitive Landscape, by Key Players, 2017
FIG. 7 Global Cryosurgery Market for SKT, 2016 – 2026 (US$ Mn)
FIG. 8 Global Electrocautery Market for SKT, 2016 – 2026 (US$ Mn)
FIG. 9 Global Curettage Market for SKT, 2016 – 2026 (US$ Mn)
FIG. 10 Global Laser Ablation Market for SKT, 2016 – 2026 (US$ Mn)
FIG. 11 Global Hydrogen Peroxide 40% Solution (Eskata) Market for SKT, 2016 – 2026 (US$ Mn)
FIG. 12 U.S. SKT Market, 2016 – 2026 (US$ Mn)
FIG. 13 Canada SKT Market, 2016 – 2026 (US$ Mn)
FIG. 14 U.K. SKT Market, 2016 – 2026 (US$ Mn)
FIG. 15 Germany SKT Market, 2016 – 2026 (US$ Mn)
FIG. 16 Rest of Europe SKT Market, 2016 – 2026 (US$ Mn)
FIG. 17 Japan SKT Market, 2016 – 2026 (US$ Mn)
FIG. 18 China SKT Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Asia Pacific SKT Market, 2016 – 2026 (US$ Mn)
FIG. 20 Brazil SKT Market, 2016 – 2026 (US$ Mn)
FIG. 21 Mexico SKT Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Latin America SKT Market, 2016 – 2026 (US$ Mn)
FIG. 23 GCC SKT Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Middle East and Africa SKT Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1. Global Seborrheic Keratosis Treatment (SKT) Market Portraiture
TABLE 2. Global SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 3. Global SKT Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4. Global Surgical Treatments Market for Seborrheic Keratosis, by Type, 2016 – 2026 (US$ Mn)
TABLE 5. Global Topical Solution Market for SKT, by Type, 2016 – 2026 (US$ Mn)
TABLE 6. North America SKT Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 7. North America SKT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8. Europe SKT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9. Europe SKT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10. Asia Pacific SKT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 11. Asia Pacific SKT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12. Latin America SKT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13. Latin America SKT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 14. Middle East and Africa SKT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15. Middle East and Africa SKT Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 16. Aclaris Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17. Cortex Technology ApS: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18. CryoConcepts LP.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19. Cryoswiss GmbH.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20. DRE Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21. EpiPharm AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22. H&O Equipments SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23. Orasure Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24. Special Medical Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25. Wallach Surgical Devices, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)